Developing countries are increasingly struggling to manage epidemic rates of chronic diseases, like diabetes, stroke, and heart disease, and it is expected that stem cell research could lead to better treatments for such chronic conditions.
In the study, by Abdallah Daar (McLaughlin Centre for Molecular Medicine, University of Toronto) and colleagues, an international panel of 44 experts ranked the ten most promising applications of regenerative medicine for improving health in developing countries. The experts included researchers in disciplines contributing to regenerative medicine and clinicians working in fields that will be at the forefront of applying regenerative medicine therapies.
The top-ranked application was novel methods of insulin replacement and pancreatic islet cell regeneration for diabetes. The panelists ranked this number one because of the high prevalence of diabetes in developing countries and the major health, social, and economic burden that results. Panelists emphasized that controlling diabetes would in turn reduce the incidence of diabetes complications such as blindness, heart disease, chronic kidney disease, and diabetic ulcers.
The panelists noted that repeated insulin treatments are costly and inaccessible to many patients in developing countries. They felt that regenerative medicine therapies, such as bone marrow stem cell transplantation or microencapsulated islet cells using new biomaterials, could provide a permanent solution to treating diabetes and reduce the financial burden caused by the purchase of insulin.
The second-ranked application was regenerating failed heart muscle using the patient's own cells, injected directly or introduced via patches, for treating heart muscle damage due to a heart attack or a cardiomyopathy (a condition causing weakness of the heart muscle). Panelists noted that such therapy shows promising early results, and is being tested in clinical trials in a number of countries.
Other highly ranked applications were immune system enhancement by engineered immune cells, new vaccination strategies for treating infectious diseases, new stem cell-based technologies for replacing skin loss due to burns, wounds, and diabetic ulcers, and new blood substitutes.
The study results, say the authors, "may be used as a guide for the policy formulation of international and bilateral aid agencies, and by developing countries to help target policy aimed at initiating or developing further their existing capacity in regenerative medicine."
On the Net:
http://dx.doi.org/10.1371/journal.pmed.0030381
Source: Public Library of Science
Related stories:
Millions face undiagnosed heart risk say researchers after mass screening
One in three people with a high risk of developing cardiovascular disease (CVD) over the next 10 years have not been diagnosed, according to a major UK study in the September issue of IJCP, the
International Journal of Clinical Practice.
Class of diabetes drugs carries significant cardiovascular risks
A class of oral drugs used to treat type 2 diabetes may make heart failure worse, according to an editorial published online in
Heart Wednesday by two Wake Forest University School of Medicine faculty members.
Young type-2 diabetic men suffer low testosterone levels, study shows
Young men with type 2 diabetes have significantly low levels of testosterone, endocrinologists at the University at Buffalo have found -- a condition that could have a critical effect on their quality of life and on their ability to father children.
Caesarean babies more likely to develop diabetes
Babies delivered by Caesarean section have a 20 per cent higher risk than normal deliveries of developing the most common type of diabetes in childhood, according to a study led by Queen's University Belfast.
Researcher develops novel method to grow human embryonic stem cells
(PhysOrg.com) -- The majority of researchers working with human embryonic stem cells (hESCs) – cells which produce any type of specialized adult cells in the human body – use animal-based materials for culturing the cells. But because these materials are animal-based, they could transmit viruses and other pathogens to the hESCs, making the cells unsuitable for medical use.
Chemists move closer toward developing safer, fully-synthetic form of heparin
Chemists are reporting a major advance toward developing a safer, fully-synthetic version of heparin, the widely used blood thinner now produced from pig intestines. The U. S. Food and Drug Administration last spring linked contaminated batches of the animal-based product, imported from China, to more than 80 deaths and hundreds of allergic reactions among patients exposed to the drug for kidney dialysis and other conditions.
Air pollution damages more than lungs: Heart and blood vessels suffer too
As athletes from around the world compete in the Beijing Olympics, many are on alert for respiratory problems caused by air pollution. They should also be concerned about its toxic effects on the heart and cardiovascular system, mounting research shows.
New discovery may lead to immunization against cardiovascular disease
Low levels of naturally occurring antibodies may represent an increased risk of developing cardiovascular disease, particularly stroke in men. This discovery, published in the academic journal
Atherosclerosis, has now led to attempts to develop an immunization against cardiovascular disease.
